Patients with Obesity Call for Fair Drug Standards: New Research Reveals Strong Demand for FDA and Industry Action on Testing and Labeling
PR Newswire —
At ObesityWeek 2025, new data show overwhelming public support for ensuring that all medications are evaluated and labeled for safety and efficacy in people with obesity. ATLANTA, Nov. 4, 2025 /PRNewswire/ -- New research presented today at ObesityWeek 2025, the world's leading...